Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11744837
Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients
granted -
US 11746077
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
granted -
US 11746151
Compositions and methods for treating cancer
granted -
US 11744887
Coronavirus vaccine compositions and methods
granted -
US 11744834
Metal-porphyrin complexes for the inactivation of the biological activity of opioids
granted -
US 11744893
Constrained conditionally activated binding proteins
granted -
US 11738035
Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
granted -
US 11739345
Methods of treating phenylketonuria
granted -
US 11737979
Method of making lipid-encapsulated RNA nanoparticles
granted -
US 11737983
Storage stable sincalide formulations
granted -
US 11739162
Side chain modified peptoids useful as structure-stabilizing coatings for biomaterials
granted -
US 11739309
CRISPR-Cas12J effector polypeptides and methods of use thereof
granted -
US 11737978
Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease
granted -
US 11739063
DREADD actuators
granted -
US 11739101
Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
granted -
US 11739123
Process for the preparation of cyclic depsipeptides
granted -
US 11739121
EPHA2 agonists and uses thereof
granted -
US 11739093
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
granted -
US 11739086
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted -
US 11737993
Multiple myeloma treatment
granted -
US 11738009
Bicyclic compounds and their use in the treatment of cancer
granted -
US 11737991
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted -
US 11738019
Substituted heterocycles as antiviral agents
granted -
US 11738022
Methods for inducing pupil dilation
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.